How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,755 results for

Mycosis Fungoides

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2. Papular Mycosis Fungoides is a Distinctive Variant of Early-stage Mycosis Fungoides: Extended Retrospective Study With Long-term Follow-up. (PubMed)

Papular Mycosis Fungoides is a Distinctive Variant of Early-stage Mycosis Fungoides: Extended Retrospective Study With Long-term Follow-up. Papular mycosis fungoides (PMF) is a rare variant of mycosis fungoides (MF). The exact nosology and prognosis of PMF are still unclear. We retrospectively identified cases of PMF from the files of the Department of Dermatology of the Medical University of Graz, Austria, and checked the follow-up data. The patients comprised 13 men and 5 women (median age

2019 American Journal of Surgical Pathology

3. Large-Cell Transformed Mycosis Fungoides Coexisting with Mycosis Fungoides Bullosa: A Case Report and Review of the Literature (PubMed)

Large-Cell Transformed Mycosis Fungoides Coexisting with Mycosis Fungoides Bullosa: A Case Report and Review of the Literature Mycosis fungoides is the most common form of cutaneous T-cell lymphoma. Both large-cell transformed mycosis fungoides and mycosis fungoides bullosa are rare presentations and predict unfavorable prognosis. We report the case of a 61-year-old woman who presented with generalized erythematous scaly annular plaques, and histopathology confirmed the diagnosis of mycosis (...) ). One day after receiving chemotherapy, multiple tense bullae on normal-appearing skin and mycosis fungoid plaques erupted. A histological study demonstrated subepidermal blistering with epidermotropism of atypical lymphocytes. Direct immunofluorescence study was negative. The results confirmed the diagnosis of mycosis fungoides bullosa. We present the first reported case of large-cell transformed mycosis fungoides coexisting with mycosis fungoides bullosa.

Full Text available with Trip Pro

2017 Case reports in dermatology

4. Corneal infiltration and xanthoma formation in mycosis fungoides (PubMed)

Corneal infiltration and xanthoma formation in mycosis fungoides To report a case of corneal infiltration and xanthoma formation in mycosis fungoides (cutaneous T-cell lymphoma).A middle aged Japanese man with mycosis fungoides (MF) involving the face was referred to Ophthalmology for evaluation of unilateral, painless conjunctival injection. Biopsy of the conjunctiva revealed a malignant T cell population consistent with MF tumor invasion. Years later, he returned following several episodes

Full Text available with Trip Pro

2018 American journal of ophthalmology case reports

5. Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®): Health Professional Version

Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®): Health Professional Version Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ (...) Cancer Information Summaries [Internet]. Bethesda (MD): ; 2002-. Search term Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®) Health Professional Version PDQ Adult Treatment Editorial Board . Published online: July 5, 2018. This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of mycosis fungoides (including Sézary Syndrome). It is intended as a resource to inform and assist clinicians who care

2018 PDQ - NCI's Comprehensive Cancer Database

6. Extracorporeal Photopheresis for Sezary Syndrome or Mycosis Fungoides: Clinical and Cost-Effectiveness

Extracorporeal Photopheresis for Sezary Syndrome or Mycosis Fungoides: Clinical and Cost-Effectiveness Extracorporeal Photopheresis for Sezary Syndrome or Mycosis Fungoides: Clinical and Cost-Effectiveness | CADTH.ca Find the information you need Extracorporeal Photopheresis for Sezary Syndrome or Mycosis Fungoides: Clinical and Cost-Effectiveness Extracorporeal Photopheresis for Sezary Syndrome or Mycosis Fungoides: Clinical and Cost-Effectiveness Published on: September 30, 2015 Project (...) Number: RB0915-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of extracorporeal photopheresis (ECP) for the management of Sezary Syndrome or Mycosis fungoides? What is the cost-effectiveness of ECP for the management of Sezary Syndrome or Mycosis fungoides? Key Message One systematic review, four non-randomized studies, and one economic evaluation were identified regarding extracorporeal

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

7. Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis (PubMed)

Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis Mycosis fungoides (MF) is a significant diagnostic challenge; it has various differential diagnosis especially at an early stage. Our aim was to describe mimics of MF clinically and histologically, and to define significant diagnostic criteria of the disease.This was a retro-prospective cohort of 370 patients in whom the diagnosis of MF was suspected clinically.MF was histologically

Full Text available with Trip Pro

2017 International journal of women's dermatology

8. A Case of Papular Mycosis Fungoides: A New Clinical Variant of Early Mycosis Fungoides (PubMed)

A Case of Papular Mycosis Fungoides: A New Clinical Variant of Early Mycosis Fungoides 27274640 2016 06 09 2018 11 13 1013-9087 28 3 2016 Jun Annals of dermatology Ann Dermatol A Case of Papular Mycosis Fungoides: A New Clinical Variant of Early Mycosis Fungoides. 383-4 10.5021/ad.2016.28.3.383 Kim Soo Jin SJ Department of Dermatology, Inje University Ilsan Paik Hospital, Goyang, Korea. Schaffer András A Dermatopathology Center, Washington University School in St. Louis, St. Louis, MO, USA. Lee

Full Text available with Trip Pro

2016 Annals of dermatology

9. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients. (PubMed)

Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients. Mycosis fungoides (MF) typically has a CD4+ CD8- T-cell phenotype. Rare cases of CD4- CD8+ , CD4- CD8- , or CD4+ CD8+ immunophenotypes have been described. Little is known about the impact of MF immunophenotypes on disease behavior.We conducted a retrospective cohort study to review all cases of MF from 2007 to 2017 from Sunnybrook Health Sciences Centre, Toronto, Canada. CD4+ CD8- (Group 1

2019 International Journal of Dermatology

10. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. (PubMed)

Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. Phototherapy is one of the mainstays of treatment for early mycosis fungoides (MF). The most common modalities are psoralen-UV-A (PUVA) and narrowband UV-B (NBUVB).To compare the efficacy and adverse effects of PUVA vs NBUVB in early-stage MF.A systematic review was performed by searching Cochrane Database of Systematic Reviews, Cochrane Central (...) Register of Controlled Trials, Ovid Medline, PubMed, Cochrane Library, American College of Physicians ACP Journal Club, and Database of Abstracts of Review of Effectiveness from inception to March 30, 2018. UV A, PUVA, mycosis fungoides, Sézary syndrome, cutaneous T-cell lymphoma, UV B, and UVB were used as either key words or MeSH terms.Studies of cohorts with histologically confirmed early-stage MF, defined as stages IA, IB, and IIA, that compared PUVA vs NBUVB, had at least 10 patients in each

2019 JAMA dermatology (Chicago, Ill.)

11. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument. (PubMed)

Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument. Although the quality of life (QoL) plays an important role in treatment decision making and clinical management of mycosis fungoides (MF) or Sézary syndrome (SS) subtypes of cutaneous T-cell lymphomas (MF/SS-CTCLs), an MF- or SS-specific measure of QoL does not exist.The objective of this research was to develop and validate the first QoL

Full Text available with Trip Pro

2019 Journal of medical Internet research

12. Ethnicity in Mycosis Fungoides: White patients present at an older age and with more advanced disease. (PubMed)

Ethnicity in Mycosis Fungoides: White patients present at an older age and with more advanced disease. 30604865 2019 01 28 1365-2133 2019 Jan 03 The British journal of dermatology Br. J. Dermatol. Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease. 10.1111/bjd.17602 Scarisbrick J J JJ Department of Dermatology, Centre for Rare Diseases, University Hospital Birmingham, Birmingham, U.K. Quaglino P P Department of Dermatology, University Hospital

2019 British Journal of Dermatology

13. Understanding racial disparities in mycosis fungoides through international collaborative studies. (PubMed)

Understanding racial disparities in mycosis fungoides through international collaborative studies. 30604871 2019 01 25 1365-2133 2019 Jan 03 The British journal of dermatology Br. J. Dermatol. Understanding racial disparities in mycosis fungoides through international collaborative studies. 10.1111/bjd.17598 Geller S S https://orcid.org/0000-0003-1206-1057 Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, U.S.A

2019 British Journal of Dermatology

14. Epidemiology and prognostic factors for mycosis fungoides and Sézary syndrome in a multi-ethnic Asian cohort: A 12-year review. (PubMed)

Epidemiology and prognostic factors for mycosis fungoides and Sézary syndrome in a multi-ethnic Asian cohort: A 12-year review. Limited information exists regarding survival of Asian patients with mycosis fungoides (MF) and Sézary syndrome (SS).To evaluate the epidemiology, outcome and prognostic factors of these patients.A retrospective review of MF/SS cases diagnosed from 2000 to 2011 at a tertiary referral dermatology centre in Singapore was performed.Of 246 patients, 63% were male

2019 Journal of the European Academy of Dermatology and Venereology

15. Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study. (PubMed)

Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study. Follicular mucinosis (FM), defined by mucin accumulation within follicular epithelium, may occur in mycosis fungoides (MF). FM without MF is occasionally reported in systemic hematologic malignancies, and may be diagnostically challenging.To describe clinicopathological characteristics of FM in patients with hematologic malignancies other than MF.Clinical data

2019 Journal of American Academy of Dermatology

16. Mycosis fungoides presenting as vulvar plaques. (PubMed)

Mycosis fungoides presenting as vulvar plaques. 30653269 2019 02 27 1468-3083 2019 Jan 17 Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Mycosis fungoides presenting as vulvar plaques. 10.1111/jdv.15429 El Alami J J Department of Dermatology, INSERM U976, Saint-Louis Hospital, APHP, Paris Diderot University, 49100 Angers, Paris, France. Le Corre Y Y Department of Dermatology, University Hospital of Angers, UBL University, Angers, 75010 Paris

2019 Journal of the European Academy of Dermatology and Venereology

17. Low- vs. Middle-dose Total Skin Electron Beam Therapy for Mycosis Fungoides: An Efficiency-based Retrospective Survey of Skin Response. (PubMed)

Low- vs. Middle-dose Total Skin Electron Beam Therapy for Mycosis Fungoides: An Efficiency-based Retrospective Survey of Skin Response. Optimal doses of total skin electron beam therapy for mycosis fungoides remain to be established. Clinical efficiency and adverse effects of middle-dose (25 Gy) vs. low-dose (10-12 Gy) total skin electron beam therapy were retrospectively compared in a series of 14 and 12 mycosis fungoides, respectively. Overall skin response rate was 96.2% (92.9% middle-dose

Full Text available with Trip Pro

2019 Acta Dermato-Venereologica

18. Ingenol mebutate for mycosis fungoides. (PubMed)

Ingenol mebutate for mycosis fungoides. Ingenol mebutate is a macrocyclic diterpene ester, naturally found in the sap of the Australian plant Euphorbia peplus, which proved efficacious for actinic keratosis. In clinical routine, we observed local improvement of MF upon application of ingenol mebutate in MF patients treated for coincidental actinic keratosis within direct proximity of/overlapping with MF skin lesions. Hence, the objective of this study was to assess the effect of topical ingenol

2019 British Journal of Dermatology

19. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome. (PubMed)

Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome. Tumor cells in cutaneous T cell lymphoma express limited numbers of chemokine receptors. We investigated the expression patterns of CXCR3, CCR3, CCR4 and CCR10 in mycosis fungoides, Sézary syndrome, lym-phomatoid papulosis and anaplastic large cell lymphoma in 121 skin biopsy samples. CXCR3 was expressed in 86% of mycosis fungoides cases but in no anaplastic large cell lymphoma cases. CCR3 (...) was expressed in 73% of cases of CD30+ lymphoproliferative disorders such as lymphomatoid papulosis and anaplastic large cell lymphoma. Mycosis fungoides/Sézary syndrome patients with high CCR3 or CCR4 expression had a poorer survival prognosis than mycosis fungoides/Sézary syndrome patients whose tumor cells did not express these receptors. CCR10 was expressed in 50% of mycosis fungoides/Sézary syndrome cases and in 13% of cases with CD30+ lym-phoproliferative disorders. These results suggest

Full Text available with Trip Pro

2019 Acta Dermato-Venereologica

20. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (PubMed)

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Mycosis fungoides (MF) and Sézary Syndrome (SS) are the most common cutaneous T-cell lymphomas. MF/SS is accompanied by considerable morbidity from pain, itching and disfigurement.To identify factors associated with poorer health-related quality of life (HRQoL) in newly diagnosed MF/SS patients.Patients

2019 British Journal of Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>